alisa_li (@alisalikhitsup) 's Twitter Profile
alisa_li

@alisalikhitsup

Gastroenterology/Hepatology | Liver disease and transplant hepatologist | @UofM

ID: 1006163810607095810

calendar_today11-06-2018 13:18:40

485 Tweet

672 Followers

482 Following

Lily Dara (@lilydaramd) 's Twitter Profile Photo

#DILI from newer IBD meds key take home Einar S. Björnsson AASLD Uma Mahadevan @GIDrHwang USC Division of GI & Liver Damie Odufalu ✅Liver injury from infliximab is usually mild without jaundice. ✅There are 10 cases in the literature leading to LT. ✅Infliximab induces a

#DILI from newer IBD meds key take home <a href="/bjornsson_s/">Einar S. Björnsson</a> <a href="/AASLDtweets/">AASLD</a> <a href="/UmaMahadevanIBD/">Uma Mahadevan</a> @GIDrHwang <a href="/USC_KeckGILiver/">USC Division of GI & Liver</a> <a href="/DamieOdufaluMD/">Damie Odufalu</a> 
✅Liver injury from infliximab is usually mild without jaundice.
✅There are 10 cases in the literature leading to LT.
✅Infliximab induces a
Journal of Hepatology (@jhepatology) 's Twitter Profile Photo

Ileitis promotes MASLD progression via bile acid modulation and enhanced TGR5 signaling in ileal CD8+ T cells Full text here👉journal-of-hepatology.eu/article/S0168-… #LiverTwitter

Ileitis promotes MASLD progression via bile acid modulation and enhanced TGR5 signaling in ileal CD8+ T cells

Full text here👉journal-of-hepatology.eu/article/S0168-…

#LiverTwitter
Arndt Vogel (@arndtvogel) 's Twitter Profile Photo

🔥Hot off the press🔥 Durvalumab or placebo plus gemcitabine and cisplatin in advanced biliary tract cancer 🔎updated overall survival from TOPAZ-1 phase 3 The Lancet Gastroenterology & Hepatology doi.org/10.1016/S2468-… 👉24-mo OS rate: 23·6% vs 11·5% ESMO - Eur. Oncology EASLnews ILCA Cholangiocarcinoma Foundation #livertwitter

🔥Hot off the press🔥
Durvalumab or placebo plus gemcitabine and cisplatin in advanced biliary tract cancer
🔎updated overall survival from TOPAZ-1 phase 3 
<a href="/LancetGastroHep/">The Lancet Gastroenterology & Hepatology</a> 
doi.org/10.1016/S2468-…
👉24-mo OS rate: 23·6% vs 11·5%
<a href="/myESMO/">ESMO - Eur. Oncology</a> <a href="/EASLnews/">EASLnews</a> <a href="/ILCAnews/">ILCA</a> <a href="/curecc/">Cholangiocarcinoma Foundation</a> #livertwitter
Robert Fontana (@robertfontanamd) 's Twitter Profile Photo

HDS Botanicals in the US: > 15 million Americans take potentially hepatotoxic HDS botanicals every Day ! Most self-initiated to “Boost Immunity or Energy” doi:10.1001/jamanetworkopen.2024.25822 Michigan Hepatology LiverTox Michigan Medicine

HDS Botanicals in the US: &gt; 15 million Americans take potentially hepatotoxic HDS botanicals every Day ! Most self-initiated to “Boost Immunity or Energy” doi:10.1001/jamanetworkopen.2024.25822 <a href="/MichiganLiver/">Michigan Hepatology</a> <a href="/livertox/">LiverTox</a> <a href="/umichmedicine/">Michigan Medicine</a>
Andrew Moon (@andrewmmoon) 's Twitter Profile Photo

The BCLC GROUP sets the standard for optimizing the nurse’s role in the patient journey nllarch gives an excellent talk at ILCA outlining how nurses play an essential role assessing preferences and improving patient experience in patients with liver cancer

The <a href="/BCLC_group/">BCLC GROUP</a> sets the standard for optimizing the nurse’s role in the patient journey 

<a href="/nllarch/">nllarch</a> gives an excellent talk at <a href="/ILCAnews/">ILCA</a>  outlining how nurses play an essential role assessing preferences and improving patient experience in patients with liver cancer
alisa_li (@alisalikhitsup) 's Twitter Profile Photo

A New”Inpt-DILI” Model Outperforms MELD and King’s College Criteria in Hospitalized Patients With Severe Idiosyncratic DILI cdmcd.co/gaRPax #ALFSG #ACG2024

A New”Inpt-DILI” Model Outperforms MELD and King’s College Criteria in Hospitalized Patients With Severe Idiosyncratic DILI   cdmcd.co/gaRPax #ALFSG #ACG2024
alisa_li (@alisalikhitsup) 's Twitter Profile Photo

Our Inpt-DILI prognostic Model will help clinicians predicting 21-day survival for patients hospitalized for severe Idiosyncratic DILI cdmcd.co/gaRPax #ALFSG #ACG2024

Our Inpt-DILI prognostic Model will help clinicians predicting 21-day survival for  patients hospitalized for severe Idiosyncratic DILI cdmcd.co/gaRPax  #ALFSG #ACG2024
Liver Transplantation Journal (LTxJournal) (@ltxjournal) 's Twitter Profile Photo

Safety and efficacy of simultaneous liver transplantation and sleeve gastrectomy in morbid obese end-stage liver disease patients: The LT-SG study journals.lww.com/lt/abstract/99…

JAMA (@jama_current) 's Twitter Profile Photo

CAR T-cell therapy has demonstrated efficacy in treating hematologic malignancies & improving overall survival for patients w/ large B-cell lymphoma. This Review describes approved indications, clinical outcomes, and emerging applications for solid tumors ja.ma/4fnIos2

CAR T-cell therapy has demonstrated efficacy in treating hematologic malignancies &amp; improving overall survival for patients w/ large B-cell lymphoma. This Review describes approved indications, clinical outcomes, and emerging applications for solid tumors ja.ma/4fnIos2
Patty Pringle Bloom, M.D. (@bloompringle) 's Twitter Profile Photo

Dr Ponni Perumalswami Perumalswami delivering a masterclass on alcohol related liver disease We are hepatologists, but we CAN and SHOULD be prescribing medication to treat alcohol use disorder Naltrexone, NNT = 7! Hard to beat.

Dr <a href="/ponnivp/">Ponni Perumalswami</a> Perumalswami delivering a masterclass on alcohol related liver disease

We are hepatologists, but we CAN and SHOULD be prescribing medication to treat alcohol use disorder

Naltrexone, NNT = 7! Hard to beat.
Arndt Vogel (@arndtvogel) 's Twitter Profile Photo

🔥off the press: Hepatocellular carcinoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up Annals of Oncology doi.org/10.1016/j.anno… 👉get the lastest update on HCC management 👉Multiple options > MDT is key ESMO - Eur. Oncology EASL Education ILCA #livertwitter

🔥off the press:
Hepatocellular carcinoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
<a href="/Annals_Oncology/">Annals of Oncology</a> 
doi.org/10.1016/j.anno…
👉get the lastest update on HCC management
👉Multiple options &gt; MDT is key
<a href="/myESMO/">ESMO - Eur. Oncology</a> <a href="/EASLedu/">EASL Education</a> <a href="/ILCAnews/">ILCA</a> #livertwitter
Journal of Hepatology (@jhepatology) 's Twitter Profile Photo

📌In our March issue Intention-to-treat outcomes of patients with hepatocellular carcinoma receiving immunotherapy before liver transplant: The multicenter VITALITY study Read it here👉journal-of-hepatology.eu/article/S0168-… #LiverTwitter

📌In our March issue

Intention-to-treat outcomes of patients with hepatocellular carcinoma receiving immunotherapy before liver transplant: The multicenter VITALITY study

Read it here👉journal-of-hepatology.eu/article/S0168-…

#LiverTwitter
Alina Allen (@alinaallenmd) 's Twitter Profile Photo

I hope the medical community and the general public grasp the results of this study. Best RCT I have seen in a while. Kudos to the research team!! 👏 Exercise is medicine.